AstraZeneca (AZN) call put ratio 1 call to 3.6 puts into shares selling off 15% on failed drug trial
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Join SI Premium – FREE
AstraZeneca (NYSE: AZN) call put ratio 1 call to 3.6 puts into shares selling off 15% on failed drug trial.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
- Micron Technology (MU) call put ratio 1.1 calls to 1 put with a focus on July 520 puts
- Increasing unusual put option volume: XLB SOLS CIA VSAT SOC NTR LPTH LION AVAV AMBA SHW FPS
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
